XEN Xenetic Bio

TIDMXEN

RNS Number : 0584X

Xenetic Biosciences PLC

07 January 2014

Xenetic Biosciences plc

(the "Company")

Exercise of Options

Xenetic Biosciences plc (AIM: "XEN"), today announces that it has applied for 173,059 new ordinary shares of 0.5 pence each to be admitted to trading on AIM as a result of the exercise of an employee option award. Admission of the new shares is expected to take place on 10 January 2014.

The Company's issued share capital, as stated in the RNS on 6 January 2014, consists of 408,048,487 ordinary shares each with one voting right. The Company does not hold any ordinary shares in treasury.

Enquiries:

 
Xenetic Biosciences plc                                www.xeneticbio.com 
M. Scott Maguire, Chief Executive Officer              +44 (0)20 3021 1500 
Colin Hill, Chief Financial Officer 
London Bridge Capital (Financial Adviser to Xenetic)   +44 (0)7912 201639 
Adam Hart 
 
N+1 Singer (Nominated Adviser & Broker)                +44 (0)20 7496 3000 
Aubrey Powell 
 
Walbrook PR                                            +44 (0)20 7933 8780 
Mike Wort (Media Enquiries)                            mike.wort@walbrookpr.com 
Paul Cornelius (Investor Enquiries)                    paul.cornelius@walbrookir.com 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCUGUBGGUPCURM

Xenetic Bio (LSE:XEN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Xenetic Bio (LSE:XEN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024